XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Impairment of equity investment $ (27,500) $ 0 $ (27,821) $ 0  
Fair value of contingent consideration liability 1,200   2,000    
Strategic investments 7,500   7,500   $ 31,321
Biotechnology Company          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Strategic investments $ 4,000   4,000    
Level 3 [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Fair value of contingent consideration liability     2,000 $ (6,700)  
Level 3 [Member] | Minimum [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity Method Investment Other Than Temporary Impairment Level 3 Input Min     0    
Level 3 [Member] | Maximum [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Equity Method Investment Other Than Temporary Impairment Level 3 Input Max     $ 2,500